Mode
Text Size
Log in / Sign up

Cushing’s Syndrome Often Leads to Fatty Liver Disease

Share
Cushing’s Syndrome Often Leads to Fatty Liver Disease
Photo by Bioscience Image Library by Fayette Reynolds / Unsplash

Fatty Liver Disease Common in Cushing’s Syndrome

A new report looks at how this hormone affects the liver. It found that more than 60% of patients have fatty liver disease. This is a condition where fat builds up inside the liver cells. It is not a rare problem for these patients.

Doctors used to focus on the hormone levels alone. They did not always check the liver closely. This new research changes how they look at the disease. It shows the liver is a major target for damage.

Liver Fat Improves After Treatment

Think of cortisol like a key that turns on fat storage. When it stays on, fat builds up in the liver. The study checked patients before and after their treatment. They found that the fat went down after the hormone levels normalized.

This improvement happened in both adrenal and pituitary cases. It means the liver can heal if the cause is fixed. But there is a catch. The scarring in the liver did not always go away.

Why Some Risks Stay Higher

Patients with high baseline fibrosis risk saw a drop. Fibrosis is the medical word for scarring in the organ. If the risk was low to start, it stayed low. But if it was high, it only went down a bit.

This doesn't mean this treatment is available yet.

The study looked at 126 adults with Cushing’s syndrome. They checked their livers using ultrasound and blood tests. The team measured fat and scarring at two different times. They compared the results to find patterns in the data.

Experts say this helps doctors know what to watch for. It changes how they check patients during their care. It is important to manage weight and blood sugar levels. These factors drive the disease more than the hormone itself.

Higher body weight and longer symptom duration were key signs. Adrenal causes of the syndrome also raised the risk. Age was linked to a lower risk in this group. This suggests younger patients need more careful monitoring.

The study had some limits that matter to you. It was not a large trial for everyone. It was also a look back at past records. This means we need more research to confirm the results.

More research is needed to see long-term effects. Doctors will keep watching how patients heal over time. Approval for new treatments takes time and careful testing. You should talk to your doctor about liver health.

Share
More on Cushing's syndrome